Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2
Peter Palmer(Eurocontrol), J. Vinke, Thierry Philip(Centre Léon Bérard), Sylvie Négrier(Centre Léon Bérard), Jens Atzpodien, Hartmut Kirchner, R. Oskam, C.R. Franks, Hans von der Maase, Nicholas Thatcher, C Jasmin, Sophie D. Fosså, Michel Symann, Lucien Israël(Centre Léon Bérard), G Nagel(Centre Léon Bérard), G. Stoter(Centre Léon Bérard), C Rugarli, O Eremin, A Iacone, F. J. Cleton, Jozef Janssens, Willems, Lothar Bergmann(Centre Léon Bérard), W. H. West, R. K. Oldham, Robert A. Dillman, Peter H. Wiernik, Charles A. Coltman, A. Raynor, James H. Doroshow, David Parkinson, E. Gallignoni, P J Guillou, Martin Gore, C.W. Keen, J. Timmons Roberts, Alexander Z. Harris, M. Fordham, P. Harper, M A Cornbleet, P Selby, Barry W. Hancock, N. Bleehan, S. J. Harland, Charles M. Rowland, Marek Ostrowski, Terry J. Hamblin, P S Veitch, M. Sokal, Paul G. Abrams, R.T.D. Oliver, H. Bodenstein, P. Czygan, PHM de Mulder, J. Wils
Cited by 156Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis